Subscribe

AEON Biopharma, Inc. (AEON)

USD0.30 -0.06 (-16.05%)
US AMEX Healthcare Biotechnology
Address 4040 Macarthur Boulevard 92614
Newport Beach, CA, US
CEO Robert Bancroft
IPO 2023-07-24
CIK 1837607 ISIN US00791X2099

Explore sections of this company profile

Also trades on NASDAQ Capital Market · PMGMW (USD) NASDAQ Capital Market · PMGM (USD) NASDAQ Capital Market · PMGMU (USD) NASDAQ Capital Market · TMKRW (USD) NASDAQ Capital Market · TMKR (USD) NASDAQ Capital Market · TMKRU (USD) New York Stock Exchange American · AEON (USD)
Description

AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.30 -0.06 (-16.05%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
78.0K
Beta
0.61
Float Shares
8.17M
Free Float %
69.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-9.91% -19.82% -29.25% -25.61% -17.06% -34.40% +41.77% -99.89% -99.89% -99.89% -99.89%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (2 ratings, all time) Buy
Price Targets & DCF
Current price
0.30
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 2 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-85.32
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
  • EPS growth Biotechnology: +29.7%
    -105.4% Q1'26: -112.7% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
  • EBIT margin Biotechnology: +0.0%
  • ROIC Biotechnology: -16.1%
    Q1'26: +116.6% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    +1,622.7% Q1'26: +919.2% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -2.12× Q1'26: -0.11× (vs Q1'25)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.66) × ERP
WACC = 17% × Ke + 83% × Kd (4.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.30
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
1 EPS Ana.
Dec 2027
1 Rev. Ana.
1 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
est: 4.18B (-100.0%)
est: 4.38B (-100.0%)
est: 1.18M (-100.0%)
16.30M
16.30M – 16.30M
+1,281.4% YoY
2.36M
2.36M – 2.36M
-85.5% YoY
87.96M
87.96M – 87.96M
+3,626.9% YoY
EBITDA
-52.74M
est: 2.51B (-102.1%)
-27.73M
-16.82M
— – —
— – —
— – —
EBIT
-52.84M
est: 2.51B (-102.1%)
-27.82M
-16.90M
— – —
— – —
— – —
Net Income
-384.63M
est: -48.52M (-692.8%)
42.01M
est: 514.34M (-91.8%)
-39.22M
est: -6.05M (-548.1%)
-19.45M
-19.45M – -19.45M
-221.3% YoY
-300.03M
-300.03M – -300.03M
-1,442.9% YoY
164.30M
164.30M – 164.30M
+154.8% YoY
SGA
19.79M
est: 7.20B (-99.7%)
13.64M
12.53M
— – —
— – —
— – —
EPS
-4.99
est: -84.24 (+94.1%)
77.74
est: 51.84 (+50.0%)
-3.95
est: -0.61 (-547.5%)
-1.96
-1.96 – -1.96
-221.3% YoY
-30.24
-30.24 – -30.24
-1,442.9% YoY
16.56
16.56 – 16.56
+154.8% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-15 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-14 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-13 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-12 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-11 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-08 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-07 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-06 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-05 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-04 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-01 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-30 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-29 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-28 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-27 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-24 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-23 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-22 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-21 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-20 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-17 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-16 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-15.23M
OE per share TTM
-2.46
Owner's Yield
-51.97%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
87.8%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
24
Total invested
2.80M
Insider transactions (90d)
1
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
24
+2 vs prev Q
New positions
9
Closed positions
7
Increased
13
Reduced
2
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 DAUNTLESS INVESTMENT GROUP, LLC 2.53M +395.9K (+18.6%) 2.49M +1.2M (+87.9%) 25.48% +3.991 pp 1.65% +0.596 pp USD0.86 +15.1% 5 qtrs
2 90.5K +90.5K (+100.0%) 89.2K +89.2K (+100.0%) 0.91% +0.912 pp 0.00% +0.000 pp USD0.99 +0.0% 1 qtrs NEW
3 GEODE CAPITAL MANAGEMENT, LLC 87.1K +26.9K (+44.8%) 85.8K +19.6K (+29.6%) 0.88% +0.271 pp 0.00% +0.000 pp USD0.90 +10.0% 4 qtrs
4 BLUE OWL CAPITAL HOLDINGS LP 42.4K -1.0K (-2.4%) 41.5K -6.2K (-13.0%) 0.43% -0.011 pp 0.01% +0.008 pp USD0.59 +67.8% 5 qtrs
5 FORMIDABLE ASSET MANAGEMENT, LLC 20.0K +20.0K (+100.0%) 22.0K +22.0K (+100.0%) 0.20% +0.202 pp 0.00% +0.003 pp USD0.98 +1.0% 1 qtrs NEW
6 XTX TOPCO LTD 20.4K -36.4K (-64.1%) 20.1K -42.4K (-67.8%) 0.21% -0.367 pp 0.00% -0.001 pp USD1.02 -2.9% 3 qtrs
7 JANE STREET GROUP, LLC 16.4K +16.4K (+100.0%) 16.1K +16.1K (+100.0%) 0.17% +0.165 pp 0.00% +0.000 pp USD0.98 +1.0% 3 qtrs
8 VANGUARD FIDUCIARY TRUST CO 14.7K +14.7K (+100.0%) 14.5K +14.5K (+100.0%) 0.15% +0.148 pp 0.00% +0.000 pp USD0.98 +1.0% 1 qtrs NEW
9 LPL FINANCIAL LLC 11.5K +11.5K (+100.0%) 11.3K +11.3K (+100.0%) 0.12% +0.116 pp 0.00% +0.000 pp USD0.98 +1.0% 1 qtrs NEW
10 UBS GROUP AG 4.2K +130.0 (+3.2%) 4.1K -337.0 (-7.6%) 0.04% +0.001 pp 0.00% +0.000 pp USD0.99 +0.0% 5 qtrs
11 BLACKROCK, INC. 2.8K +— (+0.0%) 2.8K -326.0 (-10.5%) 0.03% +0.000 pp 0.00% +0.000 pp USD0.58 +70.7% 5 qtrs
12 STEWARD PARTNERS INVESTMENT ADVISORY, LLC 1.1K +1.0K (+1,000.0%) 1.1K +974.0 (+885.5%) 0.01% +0.010 pp 0.00% +0.000 pp USD0.95 +4.2% 5 qtrs
13 CITIGROUP INC 742.00 +742.0 (+100.0%) 731.00 +731.0 (+100.0%) 0.01% +0.008 pp 0.00% +0.000 pp USD0.98 +1.0% 1 qtrs NEW
14 WOLFF WIESE MAGANA LLC 567.00 +— (+0.0%) 559.00 -65.0 (-10.4%) 0.01% +0.000 pp 0.00% +0.000 pp USD1.04 -4.8% 5 qtrs
15 TOWER RESEARCH CAPITAL LLC (TRC) 470.00 +470.0 (+100.0%) 463.00 +463.0 (+100.0%) 0.00% +0.005 pp 0.00% +0.000 pp USD0.98 +1.0% 1 qtrs NEW
16 DUPONT CAPITAL MANAGEMENT CORP 170.00 +— (+0.0%) 167.00 -20.0 (-10.7%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.58 +70.7% 5 qtrs
17 MORGAN STANLEY 150.00 +— (+0.0%) 148.00 -17.0 (-10.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.58 +70.7% 5 qtrs
18 SBI SECURITIES CO., LTD. 105.00 +— (+0.0%) 103.00 -13.0 (-11.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.57 +73.7% 5 qtrs
19 VANGUARD GLOBAL ADVISERS, LLC 102.00 +102.0 (+100.0%) 100.00 +100.0 (+100.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD0.98 +1.0% 1 qtrs NEW
20 GHP INVESTMENT ADVISORS, INC. 95.00 +— (+0.0%) 94.00 -11.0 (-10.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.75 +32.0% 5 qtrs
21 WELLS FARGO & COMPANY/MN 90.00 +— (+0.0%) 89.00 -10.0 (-10.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.58 +70.7% 5 qtrs
22 MAI CAPITAL MANAGEMENT 58.00 +— (+0.0%) 58.00 -6.0 (-9.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.57 +73.7% 5 qtrs
23 CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 1.00 +1.0 (+100.0%) 1.00 +1.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 1 qtrs NEW
24 DANSKE BANK A/S 1.00 +— (+0.0%) 1.00 +— (+0.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 5 qtrs
25 METEORA CAPITAL, LLC -4.0 (-100.0%) -4.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
26 LAIRD NORTON TRUST COMPANY, LLC -15.0K (-100.0%) -16.5K (-100.0%) 0.00% -0.151 pp 0.00% 0.000 pp USD 2 qtrs SOLD
27 CITADEL ADVISORS LLC -11.6K (-100.0%) -12.8K (-100.0%) 0.00% -0.117 pp 0.00% +0.000 pp USD 2 qtrs SOLD
28 TWO SIGMA SECURITIES, LLC -13.2K (-100.0%) -14.5K (-100.0%) 0.00% -0.133 pp 0.00% -0.002 pp USD 2 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 3 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR Portfolio Emerging Markets ETF SPEM 0.02% 3.60M 0.07%
2 State Street SPDR S&P Emerging Markets Small Cap ETF EWX 0.01% 99.4K 0.65%
3 Vanguard Extended Market ETF VXF 0.00% 67.0K 0.05%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
754.7K
Shares disposed
Cash buys
Cash sales
Net activity
+754,717
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2027-12-31 BARCLAYS PLC 10% Owner I Redeemable Warrants 152,387 11.50 1.75M 0
2026-04-02 Bencich John Officer A-Award A Class A Common Stock 754,717 0.00 754,717 D
2026-04-01 Bencich John Officer 0 0.00 0
2026-03-04 Wilson Alexander Blair Officer A-Award A Class A Common Stock 1,316,872 0.00 2,183,005 D
2026-03-04 Sy Jennifer Officer A-Award A Class A Common Stock 925,925 0.00 1,501,176 D
2026-03-04 Oh Chad Officer A-Award A Class A Common Stock 1,316,872 0.00 2,183,436 D
2026-02-17 Wilson Alexander Blair Officer A-Award A Class A Common Stock 862,500 0.00 866,133 D
2026-02-17 Sy Jennifer Officer A-Award A Class A Common Stock 575,000 0.00 575,251 D
2026-02-17 Oh Chad Officer A-Award A Class A Common Stock 862,500 0.00 866,564 D
2026-02-17 Bancroft Robert E. Director / Officer A-Award A Class A Common Stock 3,000,000 0.00 3,177,103 D
2026-01-21 Daewoong Co., Ltd 10% Owner Common Stock, $0.0001 par value per share 0 0.00 11,951,714 I
2025-05-21 Wilson Alexander Blair Officer A-Award A Restricted Stock Units 1,316,872 0.00 1,316,872 D
2025-05-21 Thunen Shelley B Director A-Award A Restricted Stock Units 308,641 0.00 308,641 D
2025-05-21 Sy Jennifer Officer A-Award A Restricted Stock Units 925,925 0.00 925,925 D
2025-05-21 PALMISANO ROBERT J Director A-Award A Restricted Stock Units 308,641 0.00 308,641 D
2025-05-21 Oh Chad Officer A-Award A Restricted Stock Units 1,316,872 0.00 1,316,872 D
2025-05-21 Forth Marc Director A-Award A Restricted Stock Units 370,370 0.00 370,370 D
2025-05-21 FISCHER JOST Director P-Purchase A Class A Common Stock 60,000 0.49 29.3K 266,785 D
2025-05-21 Carter Eric G Director A-Award A Restricted Stock Units 308,641 0.00 308,641 D
2025-05-20 FISCHER JOST Director P-Purchase A Class A Common Stock 60,000 0.51 30.4K 206,785 D
2025-05-19 FISCHER JOST Director P-Purchase A Class A Common Stock 50,000 0.50 24.9K 146,785 D
2025-05-14 Bancroft Robert E. Director / Officer A-Award A Class A Common Stock 177,103 0.00 177,103 D
2025-04-29 Bancroft Robert E. 0 0.00 0
2024-08-31 Wilson Alexander Blair Officer A-Award A Class A Common Stock 180,110 0.00 261,538
2024-08-31 Thunen Shelley B Director A-Award A Class A Common Stock 36,021 0.00 36,021
2024-08-31 Sy Jennifer Officer A-Award A Stock Option 48,063 0.83 39.9K 48,063
2024-08-31 PALMISANO ROBERT J Director A-Award A Class A Common Stock 36,021 0.00 36,021
2024-08-31 Oh Chad Officer A-Award A Class A Common Stock 192,117 0.00 292,545
2024-08-31 Forth Marc Director / Officer A-Award A Class A Common Stock 470,692 0.00 750,547
2024-08-31 FISCHER JOST Director A-Award A Stock Option 96,210 0.83 79.9K 96,210
2024-08-31 Carter Eric G Director A-Award A Class A Common Stock 36,021 0.00 36,021
2024-05-17 Sy Jennifer Officer D Stock Option 96,349 5.47 527.0K 0
2024-04-12 Park Seongsoo Director 0 0.00 0
2024-04-12 Daewoong Co., Ltd 10% Owner J-Other A Senior Secured Convertible Note 0 0.00 0
2024-04-11 Daewoong Co., Ltd 10% Owner J-Other A Senior Secured Convertible Note 0 0.00 0
2024-03-24 Daewoong Co., Ltd 10% Owner J-Other A Senior Secured Convertible Note 0 0.00 0
2024-03-19 Wilson Alexander Blair Officer A-Award A Stock Option 81,300 14.40 1.17M 81,300
2024-03-19 Thunen Shelley B Director A-Award A Stock Option 16,260 14.40 234.1K 16,260
2024-03-19 PALMISANO ROBERT J Director / 10% Owner A-Award A Stock Option 16,260 14.40 234.1K 16,260
2024-03-19 Oh Chad Officer A-Award A Stock Option 86,720 14.40 1.25M 86,720
2024-03-19 Forth Marc Director / Officer A-Award A Stock Option 212,466 14.40 3.06M 212,466
2024-03-19 FISCHER JOST Director A-Award A Stock Option 16,260 14.40 234.1K 16,260
2024-03-19 Carter Eric G Director A-Award A Stock Option 8,130 14.40 117.1K 8,130
2023-08-14 Thunen Shelley B Director A-Award A Stock Option 58,851 5.47 321.9K 58,851
2023-08-14 PALMISANO ROBERT J Director / 10% Owner A-Award A Stock Option 58,851 5.47 321.9K 58,851
2023-08-14 FISCHER JOST Director A-Award A Stock Option 58,851 5.47 321.9K 58,851
2023-08-14 Carter Eric G Director A-Award A Stock Option 58,851 5.47 321.9K 58,851
2023-08-11 Strathspey Crown Holdings Group, LLC 10% Owner S-Sale D Class A Common Stock 7,380,394 10.00 73.80M 2,031,773
2023-07-21 Wilson Alexander Blair Officer 0 0.00 0
2023-07-21 Thunen Shelley B Director 0 0.00 0
2023-07-21 Strathspey Crown Holdings Group, LLC 10% Owner D Class A Common Stock 0 0.00 9,420,370
2023-07-21 REYNOLDS PETER A Officer 0 0.00 0
2023-07-21 Priveterra Sponsor, LLC 10% Owner C-Conversion A Class A Common Stock 89,163 11.50 1.03M 6,989,163
2023-07-21 Oh Chad Officer 0 0.00 0
2023-07-21 Forth Marc Director / Officer A-Award A Stock Option 324,021 10.00 3.24M 324,021
2023-07-21 FISCHER JOST Director A-Award A Class A Common Stock 13,274 0.00 13,274
2023-07-21 Daewoong Co., Ltd 10% Owner I Common Stock, $0.0001 par value per share 0 0.00 2,400,000
2023-07-21 Carter Eric G Director 0 0.00 0
2023-07-05 Piron Cameron Director 0 0.00 0
2023-07-05 Carpou Bill Director 0 0.00 0
2023-07-05 Azar Dimitri Director 0 0.00 0
2023-07-03 Grodnensky Oleg Director / Officer / 10% Owner I Class B Common Stock 6,900,000 0.00 0
2023-02-20 BARCLAYS PLC 10% Owner 0 0.00 0
2022-12-15 Polar Asset Management Partners Inc. Director I Class A Common Stock, par value $0.0001 per share 0 0.00 300,000
2021-03-23 GLAZER CAPITAL, LLC 10% Owner S-Sale D Units 73,226 10.10 739.6K 2,709,235
2021-03-22 GLAZER CAPITAL, LLC 10% Owner S-Sale D Units 650 10.20 6.6K 2,882,461
2021-03-19 GLAZER CAPITAL, LLC 10% Owner S-Sale D Units 11,033 10.20 112.5K 2,883,111
2021-03-17 GLAZER CAPITAL, LLC 10% Owner S-Sale D Units 3,500 10.20 35.7K 2,894,144
2021-02-25 GLAZER CAPITAL, LLC 10% Owner S-Sale D Units 62,356 10.35 645.4K 2,897,644
2021-02-17 GLAZER CAPITAL, LLC 10% Owner S-Sale D Units 10,000 10.65 106.5K 2,960,000
2021-02-08 Priveterra Sponsor, LLC Director / 10% Owner D Class B Common Stock 6,900,000 0.00 0
2021-02-08 Lightman James Director 0 0.00 0
2021-02-08 Berry Lance A Director 0 0.00 0
2021-01-26 GLAZER CAPITAL, LLC 10% Owner S-Sale D Units 10,000 10.50 105.0K 2,970,000
2021-01-08 GLAZER CAPITAL, LLC 10% Owner I Class A Common Stock 0 0.00 2,980,000
2021-01-07 Tastemaker Sponsor LLC 10% Owner D Class B Common Stock 5,750,000 0.00 0
2021-01-07 Rosser Hal Director 0 0.00 0
2021-01-07 Pforzheimer Carl Andrew Director / Officer / 10% Owner I Class B Common Stock 5,750,000 0.00 0
2021-01-07 PACE DAVID Director / Officer / 10% Owner I Class B Common Stock 5,750,000 0.00 0
2021-01-07 JOHNSON STARLETTE B Director 0 0.00 0
2021-01-07 HEYER ANDREW R Director 0 0.00 0
2021-01-07 Golkin Gregory Director / Officer / 10% Owner J-Other A Class B Common Stock 1,150,000 0.00 6,900,000
2021-01-07 FEDERICO RICHARD L Director 0 0.00 0
2021-01-07 Bradley Christopher Officer 0 0.00 0

Executive team

Top executives
Shares Outstanding
11.83M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2022-08-11 D
2022-08-11 D
2021-12-29 RW
2021-10-07 S-1/A
2021-10-06 S-1/A
2021-10-04 S-1/A
2021-09-17 S-1
2021-09-14 DRS/A
2021-07-21 DRS/A
2021-06-08 DRS/A

Executive team

NameTitleCompensationGender
Chad K. Oh Chief Medical Officer 741.8K
Alex Wilson Chief Legal and Strategy Officer & Corporate Secretary 725.3K male
Robert Bancroft President, Chief Executive Officer & Director 585.3K male
Jennifer Sy Chief Accounting Officer female
John A. Bencich Chief Financial Officer male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits